“…The study of cancer has benefited preferential amplification of certain RNA species (i.e., it shows no sequence preference) nor creates significant differences in the ratios of specific aRNAs in the amplified RNA population compared with those of the initial host cell mRNA abundances 3,9 . It should be noted that if there were bias in amplification, then the bias would be linearly amplified rather than exponentially as in PCR amplification. Furthermore, aRNA has been shown to provide an accurate and precise amplification product [9][10][11][12] . aRNA has been used extensively to generate probes for northern and Southern blotting, in tandem with PCR 13,14 and microarrays 4,12,15,16 , and for sequencing of tissue-isolated RNA 7,10,17,18 .…”